Strides gets FDA nod for generic UrsoUrsodiol tablets had a market value of approximately $35 million, according to IQVIA June 2020 data. Teva intros generic MoviPrepTeva's generic MoviPrep is available in dosage strengths of 100 g, 7.5 g, 2.691 g, 1.015 g, 5.9 g and 4.7 g. Zydus Cadila receives FDA blessing for generic Renvela Zydus Cadila's generic Renvela is indicated to prevent hypocalcemia in chronic kidney disease patients who are on dialysis. Indoco Remedies obtains FDA OK for generic Zyprexa Olanzapine tablets have a market value of $65 million, according to IQVIA data. Alembic obtains 2 FDA approvals, 1 tentative Desonide lotion 0.05% had a market value of $7 million, and empagliflozin and linagliptin tablets, 10 mg/5 mg and 25 mg/5 mg, had a market value of $244 million for the 12 months ended June 2020. Alembic rolls out generic Differin Gel Alembic’s adapalene gel is available in a 45-mg gel tube and a 45-mg gel pump. Dr. Reddy’s launches generic Cuprimine For the year ended June 2020, the Cuprimine brand and generic equivalents had a 12-month market value of $80 million, according to IQVIA data. FDA clears Amneal’s lidocaine patch 5% The product had annual sales of roughly $282 million for the year ended June 2020, according to IQVIA data. Actavis’ Alimta generic approved by FDA The Food and Drug Administration has approved Actavis’ pemetrexed, a generic of the branded chemotherapy treatment Alimta, in three dosage strengths. AAM names president, CEO Dan Leonard joins the Association for Accessible Medicines from the National Pharmaceutical Council, where he was president and CEO. First Previous 132 133 134 135 136 Next Last